Guinea Pig Antibody Library Construction by Phage Display

Guinea Pig Antibody Library Constructionby Phage Display

Creative Biolabs builds guinea pig scFv/Fab phage display libraries with species-aware VH/VL recovery, explicit pairing strategy, repertoire QC, and optional downstream screening.

Guinea Pig Antibody Library Construction by Phage Display

Creative Biolabs builds guinea pig antibody phage display libraries for research programs that need to recover VH/VL repertoires from defined immune material and convert them into reusable recombinant screening libraries. The project can be organized within custom phage display library construction and coordinated with antibody library construction. Spleen, PBMC/peripheral lymphocytes, other approved lymphoid material, RNA, or cDNA may be evaluated, with scFv/Fab architecture and downstream selection designed around the target context.

The schematic of guinea pig. (Creative Biolabs Authorized)

Service at a Glance

Guinea Pig Antibody Library Construction by Phage Display service scope
Service ComponentProject Scope
Starting MaterialsGuinea pig spleen, PBMC/peripheral lymphocytes, other approved lymphoid material, RNA, or cDNA with immune-history metadata.
Library FormatsscFv or Fab libraries, with conventional combinatorial chain assembly described explicitly during project design.
Core ConstructionGuinea pig VH/VL recovery, controlled pooling, fragment assembly, cloning, phage rescue, and library amplification.
QC OptionsInsert and sequence checks, repertoire distribution, redundancy, display competence, propagation-bias review, and optional NGS.
Optional Downstream ScreeningPurified-antigen, peptide, cell-based, subtractive, or competitive selection with target-appropriate confirmation.

Two design questions deserve early attention: how well the guinea pig repertoire can be recovered with species-appropriate amplification, and whether the project needs native heavy/light-chain pairing or is suited to a conventional combinatorial phage display library. Clarifying both points prevents a bulk library from being asked to answer a lineage question it was not designed to preserve.

Design Consideration: Native Heavy/Light-Chain Pairing

Design Consideration: Native Heavy/Light-Chain Pairing
Library ApproachWhat the Library RepresentsWhen It Fits
Conventional combinatorial scFv/FabVH and VL populations are recovered separately and reassembled during library construction, generating a displayable combinatorial repertoire.Binder discovery where broad recombinant sampling and phage selection are the main objective.
Pairing-preserving strategyA project specifically designed to retain the original heavy/light pairing from source B cells before downstream expression or display.Studies where exact native antibody lineage or original chain pairing is a primary biological requirement.

Standard bulk scFv/Fab phage display construction is generally combinatorial. If exact native pairing is central to the research question, that requirement should be discussed before the library route is selected rather than inferred from a conventional pooled repertoire workflow.

Guinea Pig Library Construction Workflow

  1. 01

    Qualify sample and target context.

    Record immune status, sample source, collection timing, RNA quality, antigen format, and any anticipated negative-selection materials.

  2. 02

    Generate or qualify cDNA.

    Convert RNA when required and review input quality because degraded or low-complexity material can narrow the recoverable repertoire before cloning.

  3. 03

    Recover VH and VL pools.

    Use project-selected guinea pig primer sets, with separate reactions or balanced pooling where useful to monitor strong amplicon dominance.

  4. 04

    Assemble and clone scFv or Fab constructs.

    Define orientation, linker or constant-domain context, cloning junctions, reading frame, and a compatible display system.

  5. 05

    Rescue, amplify, and release.

    Generate the phage library, monitor propagation as a potential bottleneck, and complete insert, sequence, repertoire, and display QC before optional selection.

QC and Deliverables

Library Quality

QC focuses on construction integrity, sequence productivity, repertoire distribution, and display competence. Insert sampling can verify expected architecture and productive sequence; Sanger data or the Phage Display NGS Service can be used to examine redundancy, variable-family representation, CDR distributions, and strong frequency shifts when deeper profiling is justified.

Creative Biolabs can provide a construction handoff that includes the library material, clone-recovery or titer information, insert and sequence sampling, diversity observations, display-related QC, and a technical report. For guinea pig libraries, primer-panel performance and sample-source context are retained in the interpretation because both directly affect what repertoire reaches the final pool.

Downstream Selection

Antigen Presentation and Screening Strategy

Antigen quality is part of the selection design. A soluble recombinant protein, peptide, membrane-associated antigen, or native cell-surface target can present different epitopes and different background liabilities. Target presentation, tags, host-cell background, and related antigens should therefore be considered before the final screening plan is fixed.

When binder discovery is included, the qualified library can proceed to Immunized Library Screening. Purified-antigen, cell-based, subtractive, or competitive routes can then be paired with ELISA, cell-based assays, flow cytometry, SPR, BLI, or another target-appropriate confirmation method. Reformatting of selected fragments is followed by renewed binding assessment.

What to Send Us

Feasibility Review
Laboratory researcher working in a lab. (Creative Biolabs Authorized)

For a focused feasibility review, send the following project information for the guinea pig library:

Project Information
  • Species / strain: guinea pig strain/species and donor information where relevant
  • Sample type: available cells, tissue, RNA, or cDNA
  • Immune history: immunization, exposure, or study background
  • Collection timing: sampling point relative to immunization or the study design
  • RNA / cDNA status: material condition, available quantity, and existing quality information
  • Desired format: scFv or Fab, plus any anticipated reformatting
  • Screening / QC requirement: antigen format, pairing requirement, negative-selection needs, screening plan, and QC depth

Creative Biolabs can use these inputs to define a research-use-only construction plan and, when requested, connect it to downstream screening and candidate confirmation.

Published Data

V–J gene segment usage distributions in spleen- and lymph-node-derived naïve B cells from individual guinea pigs. (OA Literature)
Fig.1 V and J gene segment usages in naïve B cells from individual guinea pigs. 1
01 / LITERATURE EVIDENCEPublished Data

Deep sequencing of the expressed guinea pig immunoglobulin repertoire provides useful evidence that both heavy- and light-chain diversity should be considered explicitly when planning recombinant antibody libraries. In one study, nearly 16,000 full-length VH, Vκ, and Vλ sequences were analyzed from naive B cells and antigen-specific plasma cells. Approximately 70% of potentially functional heavy-chain V segments, 73% of kappa V segments, and 81% of lambda V segments were observed in rearranged transcripts, indicating broad use of the annotated germline repertoire rather than dependence on only a few variable genes. V- and J-segment usage was not uniform, and antigen-specific plasma cells showed preferential gene usage together with increased somatic mutation, particularly within CDR1 and CDR2. These data do not measure phage-display performance, but they are highly relevant to library design because they show that primer coverage, light-chain representation, sample source, and sequence-based repertoire assessment can affect what is recovered from guinea pig material. A library intended to reflect the source repertoire should therefore be evaluated beyond total clone number alone.

Project FAQs

Which guinea pig materials can be used for library construction?
Spleen, PBMC/peripheral lymphocytes, other approved lymphoid sources, RNA, or cDNA may be considered. Suitability depends on immune context, collection timing, preservation, quantity, and nucleic-acid quality, so sample history should accompany the material whenever possible.
How are species-specific primers evaluated?
Primer selection is checked against available guinea pig variable-region information and the expected amplification pattern. Amplicon balance and sequence sampling can reveal major family dropout or dominance, with deeper repertoire profiling added when the project needs it.
Can cell-based panning be added after construction?
Yes. Cell-based selection can be used when the target is better represented in a membrane context. The plan should define target-positive and target-negative cells, expression status, background controls, and the assay used to confirm enriched clones.
Does a conventional guinea pig scFv or Fab library preserve native heavy/light-chain pairing?
Not usually. Conventional combinatorial library construction recovers VH and VL populations separately and reassembles them during scFv or Fab construction, so the original B-cell pairing is generally not retained unless a pairing-preserving method is specifically included. This distinction should be considered when native lineage reconstruction is central to the study.
When should Fab be considered instead of scFv for a guinea pig library?
Fab can be considered when separate heavy- and light-chain architecture or additional domain context is useful for the intended screening and downstream format. scFv provides a more compact display unit. The decision should reflect cloning complexity, expression behavior, target presentation, and the planned confirmation or reformatting route.

Reference

  1. Matsuzawa, Shun, Masaharu Isobe, and Nobuyuki Kurosawa. "Guinea Pig Immunoglobulin VH and VL Naïve Repertoire Analysis." PLOS ONE 13.12 (2018): e0208977. Distributed under the Creative Commons Attribution License (CC BY), without modification. https://doi.org/10.1371/journal.pone.0208977.
×
Online Inquiry

Please kindly note that our services can only be used to support research purposes (Not for clinical use).

Biophage Technology

Creative Biolabs is a globally recognized phage company. Creative Biolabs is committed to providing researchers with the most reliable service and the most competitive price.

Contact Us
  • Global Locations
Privacy Policy | Cookie Policy | Copyright © 2026 Creative Biolabs. All rights reserved.